Pathophysiology and treatment of hypertrophic cardiomyopathy.
All patients with hypertrophic cardiomyopathy (HCM) should have five aspects of care addressed. An attempt should be made to detect the presence or absence of risk factors for sudden arrhythmic death. If the patient appears to be at high risk, discussion of the benefits and risks of ICD are indicated, and many such patients will be implanted. Symptoms are appraised and treated. Bacterial endocarditis prophylaxis is recommended. Patients are advised to avoid athletic competition and extremes of physical exertion. First degree family members should be screened with echocardiography and ECG.
Sherrid
Mark V
MV
Hypertrophic Cardiomyopathy Program and Echocardiography Laboratory, Department of Medicine, Division of Cardiology, St. Luke's-Roosevelt Hospital Center, College of Physicians and Surgeons, Columbia University, New York, NY, USA. msherrid@chpnet.org
D006348:Cardiac Surgical Procedures / Q000379:methods*; D002312:Cardiomyopathy, Hypertrophic / Q000503:physiopathology* / Q000628:therapy*; D002317:Cardiovascular Agents / Q000627:therapeutic use*; D004554:Electric Countershock / Q000379:methods*; D006801:Humans; D011379:Prognosis; D013318:Stroke Volume / Q000502:physiology*
D002317:Cardiovascular Agents